by HealthDay Reporter | May 30, 2024
Common manifestations include neutrophilic dermatoses, vasculitis, granulomatous, connective tissue disease. Cutaneous manifestations of myelodysplastic syndrome (MDS) are described in a perspective piece published in the April issue of Skin Health and...
by HealthDay Reporter | May 28, 2024
Those ending sFU had lower hospital visits per patient-year and longer time to first infection with no decrease in overall survival. For select patients with asymptomatic, lower-risk chronic lymphocytic leukemia, ending specialized follow-up (sFU) is...
by HealthDay Reporter | May 24, 2024
Increase seen in hemoglobin levels, and reduction seen in fatigue and in reticulocyte and bilirubin levels. The first-in-class oral factor B inhibitor iptacopan improves hematologic and clinical outcomes in anti-C5-treated patients with persistent anemia...
by HealthDay Reporter | May 22, 2024
Increased risks seen for those with baseline hemochromatosis diagnoses and for those undiagnosed with hemochromatosis. Male and female p.C282Y homozygotes, including those undiagnosed with hemochromatosis, have increased morbidity risks, according to a...
by HealthDay Reporter | May 20, 2024
Increased risk for meningioma seen with use of medrogestone, medroxyprogesterone acetate, promegestone. Prolonged use of medrogestone, medroxyprogesterone acetate, and promegestone is associated with an increased risk for intracranial meningioma,...
